When to Intervene a Symptomatic Carotid Stenosis?

When to Intervene a Symptomatic Carotid Stenosis

Guidelines recommend that carotid endarterectomy be performed within two weeks of stroke in patients with symptomatic carotid stenosis.

 

Because a Swedish registry study showed patients treated within the first days after a transient ischemic attack or stroke are at increased risk of death and perioperatory stroke, this study aims at verifying this risk in another series of patients in Germany.

 

It included 56,336 elective carotid endarterectomies performed in patients with symptomatic stenosis between 2009 and 2014. The overall population was divided in four cohorts according to time interval between index event and surgery.

Cohort 1: 0 to 2 days.

Cohort 2: 3 to 7 days.

Cohort 3: 8 to 14 days.

Cohort 4: 14 to 180 days.

 

Primary end point was stroke or inhospital death. A multilevel multivariable regression model was used for risk adjusted analyzis, given the differences between cohorts.

 

With a mean age of 71.1±9.6 years and 67.5% men, the overall rate of any stroke or death was 2.5% (n=1.434).

 

Risk of any inhospital stroke or death was:

  • 3% for the group intervened within 48 hours of index event
  • 2.5% for the group intervened between days 3 and 7
  • 2.6% for the group intervened between days 7 and 14
  • 2.3% for those intervened between days 14 and 180

 

At multivariable analyzis, the study showed the time of intervention was not significantly associated to events.

 

Even though this study does not assess recurrent events in patients awaiting intervention, but only inhospital events post procedure, we are well aware patients are a high risk of events and, therefore, early intervention is recommended.

 

Historically, early intervention has been resisted by surgeons, because of the supposedly high periprocedural events rate. Mostly, they have tried to “cool the case down”.

 

Conclusion

A shorter time interval between index event and carotid endarterectomy was not associated with an increased risk of peri-procedural events such as death or stroke in patients with symptomatic carotid stenosis.

 

Original Title: Short Time Interval Between Neurologic Event and Carotid Surgery Is Not Associated With an Increased Procedural Risk.

Reference: Pavlos Tsantilas et al. Stroke. 2016 Oct 13. Epub ahead of print.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Therapeutic strategies in carotid free-floating thrombus: evidence and controversies

Carotid free-floating thrombus (cFFT) is a rare entity with a high embolic risk, associated with acute neurological events such as stroke or transient ischemic...

ACC 2026 | SirPAD Trial: Sirolimus-coated balloon angioplasty in infrainguinal arterial disease

Paclitaxel-coated balloons have demonstrated improved patency in peripheral arterial disease (PAD), although questions remain regarding safety and applicability across different vascular territories. In this...

ACC 2026 | HI-PEITHO: Catheter-directed strategy (EKOS) in intermediate-risk acute pulmonary embolism

The treatment of intermediate-risk pulmonary embolism (PE) continues to be an area of therapeutic uncertainty. The initial PEITHO study (2014) demonstrated a reduction in...

ACVC 2026 | FLASH Registry European Cohort: Mechanical Thrombectomy in Pulmonary Embolism

The management of intermediate-high and high-risk pulmonary embolism (PE) remains an area of therapeutic uncertainty, particularly in patients with right ventricular (RV) dysfunction, in...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

High Ischaemic Risk Criteria in Chronic Coronary Syndrome: Prevalence and Prognosis

Despite advances in the management of chronic coronary syndrome (CCS), including the widespread use of drug-eluting stents (DES) and the optimization of medical therapy,...

Management of Valve Thrombosis in TAVI: Current Evidence-Based Approach

The expansion of transcatheter aortic valve implantation (TAVI) into younger and lower-risk populations has brought bioprosthetic valve thrombosis to the forefront as a clinically...

Experience with the intra-annular self-expanding Navitor valve: data from the STS/ACC TVT registry

The expansion of TAVI, with the introduction of new-generation devices, has prioritized not only periprocedural safety, but also the preservation of coronary access, more...